Medical/Pharmaceuticals

Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for Colorectal Cancer

SUZHOU, China, Oct. 27, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC P...

2025-10-27 09:51 1190

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

SHANGHAI and HONG KONG, Oct. 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune dis...

2025-10-27 09:00 2002

Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team

SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr.Jarrod Frizzell of The Christ Hospital (Cincinnati, OH) presented real-world studies¹,² demonstrating that the EggNest™ Complete Radiation Protection System from Egg Medical, In...

2025-10-27 01:00 1509

Indonesia's Legacy in the Global Vaccine Landscape, Bio Farma and DCVMN Strengthen Health Resilience Through Global Partnership

BANDUNG, Indonesia, Oct. 25, 2025 /PRNewswire/ -- Through PT Bio Farma (Persero),Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers' Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN's...

2025-10-25 18:52 2722

MHTC WELCOMES ROYAL OMAN POLICE TO ENHANCE GOVERNMENT-TO-GOVERNMENT COOPERATION

KUALA LUMPUR, Malaysia, Oct. 25, 2025 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) concluded a four-day familiarisation visit by seniorRoyal Oman Police (ROP) officials from 21 to 24 October 2025. The delegation, led by Brigadier DrNaseer Al-Manthery, Director General of Medical Serv...

2025-10-25 17:04 2734

MindHYVE.ai™ and Prime Institute of Health Sciences (PIHS) Launch Landmark AI Partnership to Transform Education and Healthcare in Pakistan

ISLAMABAD, Oct. 25, 2025 /PRNewswire/ -- MindHYVE.ai™, a global leader in agentic artificial intelligence and adaptive learning technologies, has announced a landmark partnership with the Prime Institute of Health Sciences (PIHS) inIslamabad, marking a defining milestone in Pakistan's AI transfo...

2025-10-25 02:18 2708

Embracing the Gift of Life, Healing Little Hearts Together

Pantai Hospital Kuala Lumpur and Shangri-La Kuala Lumpur Unites Again to Support Children with Congenital Heart Disease for the Second Year KUALA LUMPUR, Malaysia, Oct. 24, 2025 /PRNewswire/ -- In a powerful display of compassion, purpose, and partnership, Pantai Hospital Kuala Lumpur (PHKL) and...

2025-10-24 22:04 2271

A Self-Reliant Future through HPV 9-Valent Vaccine Alliance: INNOVAX details Localization Strategy in Thailand at IPVS 2025

BANGKOK, Oct. 24, 2025 /PRNewswire/ -- On October 23, 2025, Dr. Zhiming ( Tiffany) Jiang, General Manager of Wantai Group, and Dr. Huirong (Harry) Pan, General Manager of Xiamen Innovax Biotech Co., Ltd. ("Innovax"), participated in the 37th International Papillomavirus Society (IPVS) Conference i...

2025-10-24 20:20 1775

The Future of Life Sciences, Omics and AI Examined by Leading Global Genomic Experts

Groundbreaking Human-Centric Genomic Foundation Model Unveiled HANGZHOU, China, Oct. 24, 2025 /PRNewswire/ -- The future of Omics and AI in life sciences is the central theme for more than 100 scientists and guests from 19 countries and regions gathered inHangzhou, China, for the 20th Annual Mee...

2025-10-24 18:13 1271

Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection

BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016 for the treatment of Hepatitis D Virus (HDV) infec...

2025-10-24 18:12 2415

Pfizer and BioNTech Receive Health Sciences Authority Approval for SARS-CoV-2 Sublineage LP.8.1-Adapted Monovalent COVID-19 Vaccine in Singapore

* The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinics inOctober 2025 for individuals 6 months of age and older. SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNT...

2025-10-24 17:33 1399

Gushengtang TCM and 1doc Form Strategic Partnership to Establish Singapore's Integrated TCM Service Model

SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- Gushengtang TCM officially launched its "Master TCM AI" system at GovWare 2025 onOctober 22. The launch coincides with a strategic partnership with 1doc and a signed agreement with August Global Partners (AGP) for strategic investment, supporting the shift...

2025-10-24 15:08 1339

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022

SUZHOU, China, Oct. 24, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen University Cancer Center in the phase I clinical study (Study ID: JSKN022-101) of JSKN022, an independently developed innovative bispeci...

2025-10-24 12:56 1292

/C O R R E C T I O N -- IFPA/

In the news release, World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis, issued23-Oct-2025 by IFPA over PR Newswire, we are advised by the company that the quotation byFrida Dunger, Executive Director of IFPA, should read "It's also time to move towards increased understa...

2025-10-24 05:15 2117

A New Era in Cervical Cancer Elimination: INNOVAX Presents Global Progress with HPV 9-Valent Vaccine on IPVS 2025 Opening Day

BANGKOK, Thailand, Oct. 23, 2025 /PRNewswire/ -- Xiamen Innovax Biotech Co., Ltd. ("INNOVAX") participated in the 37th International Papillomavirus Society (IPVS) Conference, and hosted a dedicated symposium titled "A New Era of HPV Vaccines: The Efforts from Developing Country Manufacturers for ...

2025-10-23 23:24 1548

Avaz Joins the PRC-Saltillo Community, Expanding Global AAC Access and Multilingual Innovation

SINGAPORE, Oct. 23, 2025 /PRNewswire/ -- PRC-Saltillo , the parent company of PRC Saltill...

2025-10-23 23:00 1479

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (OD...

2025-10-23 20:15 913

ArisGlobal Receives Frost & Sullivan's 2025 Global Intelligent MedDRA Coding New Product Innovation Recognition for AI Leadership and Customer Impact

ArisGlobal is honored for its technological breakthrough in intelligent MedDRA coding that enhances accuracy, accelerates compliance workflows, and advances innovation in pharmacovigilance. SAN ANTONIO, Oct. 23, 2025 /PRNewswire/ -- Frost & Sullivan

2025-10-23 20:05 997

Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific

With a strong track record across APAC, Francis Wan's appointment marks a powerful acceleration of Medison's growth in the region ZUG, Switzerland, Oct. 23, 2025 /PRNewswire/ -- Medison , the creator of a first-of-its-kind unified global commercialization platform...

2025-10-23 19:00 1169

TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging

MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today welcomes updated guidelines from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Nuclear Medicine (EANM) and The Ame...

2025-10-23 19:00 1358
1 ... 20212223242526 ... 394